Rasa Sabaliauskaitė

ORCID: 0000-0002-3465-3558 · 3 papers in corpus
2025
Biomedicines ·doi:10.3390/biomedicines13020441

Background: Ovarian cancer (OC) is the third most common and second most lethal onco-gynecological disease in the world, with high-grade serous ovarian cancer (HGSOC) making up the majority of OC cases worldwide. The current serological bio…

2023
International journal of molecular sciences ·doi:10.3390/ijms24065854

Ovarian cancer (OC) is among the deadliest gynaecologic malignancies in the world. The majority of OC patients are diagnosed at an advanced stage, with high-grade serous OC (HGSOC). The lack of specific symptoms and suitable screening strat…

review 2022
International journal of molecular sciences ·doi:10.3390/ijms232213670

Ovarian cancer (OC) is the fifth leading cause of women's death from cancers. The high mortality rate is attributed to the late presence of the disease and the lack of modern diagnostic tools, including molecular biomarkers. Moreover, OC is…